Matches in Nanopublications for { ?s ?p "[The BCR-ABL1 fusion gene, encoding a constitutively active tyrosine kinase, is thought to be sufficient to cause chronic phase (CP) CML, whereas additional genetic lesions are needed for progression into CML BC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- assertion description "[The BCR-ABL1 fusion gene, encoding a constitutively active tyrosine kinase, is thought to be sufficient to cause chronic phase (CP) CML, whereas additional genetic lesions are needed for progression into CML BC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The BCR-ABL1 fusion gene, encoding a constitutively active tyrosine kinase, is thought to be sufficient to cause chronic phase (CP) CML, whereas additional genetic lesions are needed for progression into CML BC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The BCR-ABL1 fusion gene, encoding a constitutively active tyrosine kinase, is thought to be sufficient to cause chronic phase (CP) CML, whereas additional genetic lesions are needed for progression into CML BC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The BCR-ABL1 fusion gene, encoding a constitutively active tyrosine kinase, is thought to be sufficient to cause chronic phase (CP) CML, whereas additional genetic lesions are needed for progression into CML BC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1247439.RAzgO6rI_azjuHjY6eB8l0SfEIgelXTQcJOL9CIcMPB0M130_assertion description "[The BCR-ABL1 fusion gene, encoding a constitutively active tyrosine kinase, is thought to be sufficient to cause chronic phase (CP) CML, whereas additional genetic lesions are needed for progression into CML BC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1247439.RAzgO6rI_azjuHjY6eB8l0SfEIgelXTQcJOL9CIcMPB0M130_provenance.
- NP1247442.RAwtAYl1Hb3dDD4FhTzDYzPWWzzDs10lBOBdxnPu-j_Fw130_assertion description "[The BCR-ABL1 fusion gene, encoding a constitutively active tyrosine kinase, is thought to be sufficient to cause chronic phase (CP) CML, whereas additional genetic lesions are needed for progression into CML BC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1247442.RAwtAYl1Hb3dDD4FhTzDYzPWWzzDs10lBOBdxnPu-j_Fw130_provenance.
- NP1247441.RAfrVTHSj3DDOvVxcMGbMiD021_0PU24qDGfwjX4oas3s130_assertion description "[The BCR-ABL1 fusion gene, encoding a constitutively active tyrosine kinase, is thought to be sufficient to cause chronic phase (CP) CML, whereas additional genetic lesions are needed for progression into CML BC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1247441.RAfrVTHSj3DDOvVxcMGbMiD021_0PU24qDGfwjX4oas3s130_provenance.
- NP1247440.RAGp-KtkoeVMPO7x37IAgelXicNyk2AuzHbZCvUcKEKE4130_assertion description "[The BCR-ABL1 fusion gene, encoding a constitutively active tyrosine kinase, is thought to be sufficient to cause chronic phase (CP) CML, whereas additional genetic lesions are needed for progression into CML BC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1247440.RAGp-KtkoeVMPO7x37IAgelXicNyk2AuzHbZCvUcKEKE4130_provenance.